Antiresorptive therapies for the treatment of postmenopausal osteoporosis include bisphosphonates, estrogen, selective estrogen receptor modulators and calcitonin, all of which lessen the risk of ...
Estrogen functions through binding of two different estrogen receptors (ESRs), ESR1 and ESR2. Estrogen plays an important role in bone biology, best illustrated by three points of observations ...
The second issue is that women go through menopause. Menopause is when your ovaries stop making the larger amounts of estrogen that they were previously making. And when estrogen levels dip ...
Trends in the use of different treatments for osteoporosis among the civilian ... treatments analyzed included oral and transdermal estrogen and estrogen and progesterone combination products ...
Well osteoporosis is more common in women than men and it's particularly an issue after the menopause because when you stop producing estrogen, you will start losing bone. Other risk factors could ...
several factors play a role in osteoporosis development. Hormonal changes including decreased testosterone levels in men and decreased estrogen levels in postmenopausal women, can cause this ...
During menopause, women experience a reduction in estrogen, which supports bone density, according to the Bone Health and Osteoporosis Foundation (BHOF). This decline can lead to a rapid decrease ...